StoneX Group’s Achieve Life Sciences QUIT Stock Holding History

StoneX Group’s Portfolio QUIT Stock Details QUIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-16,342	Closed	-$86.5K	–	1940
2026 Q2	$86.5K	Buy	+16,342	New	+$77.9K	﹤0.01%	1185

Other funds holding QUIT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

StoneX Group's QUIT Position: Q3 2026 in Review

StoneX Group sold out of Achieve Life Sciences (QUIT) in Q3 2026, closing a stake of 16,342 shares — an estimated $86.5K sold.

StoneX Group first reported a position in QUIT in Q2 2026 and held it in 1 quarter. The position peaked at $86.5K in Q2 2026. 42 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

StoneX Group reported no remaining Achieve Life Sciences position as of Q3 2026 after selling out during the quarter.
StoneX Group sold 16,342 Achieve Life Sciences shares in Q3 2026, an estimated $86.5K.
StoneX Group first reported a position in Achieve Life Sciences in Q2 2026 and held it in 1 quarter.
StoneX Group's Achieve Life Sciences position peaked at $86.5K in Q2 2026.
42 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.